Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Johnson and Johnson
Queensland Health
Farmers Insurance
Express Scripts
Argus Health

Generated: October 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078938

« Back to Dashboard
NDA 078938 describes TAMSULOSIN HYDROCHLORIDE, which is a drug marketed by Synthon Pharms, Alkem Labs Ltd, Mylan, Anchen Pharms, Sandoz, Zydus Pharms Usa Inc, Teva Pharms, Sun Pharm Inds Ltd, Aurobindo Pharma Ltd, Wockhardt, Macleods Pharms Ltd, and Impax Labs, and is included in twelve NDAs. It is available from fifty-two suppliers. Additional details are available on the TAMSULOSIN HYDROCHLORIDE profile page.

The generic ingredient in TAMSULOSIN HYDROCHLORIDE is tamsulosin hydrochloride. There are thirty-two drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the tamsulosin hydrochloride profile page.

Summary for NDA: 078938

Therapeutic Class:Genitourinary Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 078938

Mechanism of ActionAdrenergic alpha-Antagonists

Suppliers and Packaging for NDA: 078938

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
tamsulosin hydrochloride
CAPSULE;ORAL 078938 ANDA Blenheim Pharmacal, Inc. 10544-550 10544-550-30 30 CAPSULE in 1 BOTTLE (10544-550-30)
tamsulosin hydrochloride
CAPSULE;ORAL 078938 ANDA STAT RX USA LLC 16590-298 16590-298-30 30 CAPSULE in 1 BOTTLE (16590-298-30)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength0.4MG
Approval Date:Apr 27, 2010TE:ABRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Harvard Business School
Daiichi Sankyo
Federal Trade Commission
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus